Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 016403

Expand all

HYPAQUE (DIATRIZOATE MEGLUMINE)
30%
Marketing Status: Discontinued

Active Ingredient: DIATRIZOATE MEGLUMINE
Proprietary Name: HYPAQUE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 30%
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N016403
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: GE HEALTHCARE
Marketing Status:  Discontinued
Patent and Exclusivity Information

HYPAQUE (DIATRIZOATE MEGLUMINE)
60%
Marketing Status: Discontinued

Active Ingredient: DIATRIZOATE MEGLUMINE
Proprietary Name: HYPAQUE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 60%
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N016403
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: GE HEALTHCARE
Marketing Status:  Discontinued
Patent and Exclusivity Information

HYPAQUE-CYSTO (DIATRIZOATE MEGLUMINE)
30%
Marketing Status: Discontinued

Active Ingredient: DIATRIZOATE MEGLUMINE
Proprietary Name: HYPAQUE-CYSTO
Dosage Form; Route of Administration: SOLUTION; URETHRAL
Strength: 30%
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N016403
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: GE HEALTHCARE
Marketing Status:  Discontinued
Patent and Exclusivity Information